2026年6月最新影响因子数据已更新,欢迎查询使用。如果您对期刊系统有任何需求或者问题,欢迎反馈给我们。
![]() |
体验更多LetPub AI科研工具 >> | |
| 近期推荐: | 热 全流程投稿协助套餐服务 | 热 SCI论文AI润色+人工QC服务 | 热 Springer Nature特刊征稿 | 新 已发表SCI?是时候来Springer出书了! |
| |
| 基本信息 | 登录收藏 | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字![]() | Cancer Cell International CANCER CELL INT (此期刊被最新的JCR期刊SCIE收录) LetPub评分 6.7
88人评分
我要评分
声誉 7.2 影响力 6.0 速度 7.4 | |||||||||||||||||||||||||
| 期刊ISSN | 1475-2867 | 安装APP,查看期刊最新消息
| ||||||||||||||||||||||||
| 2025-2026最新IF (数据来源于网友提供) | 注册或登录后,查看IF | |||||||||||||||||||||||||
| 实时影响因子 | 截止2026年5月06日:6.99 | |||||||||||||||||||||||||
| 2025-2026自引率 | 1.4%点击查看自引率趋势图 | |||||||||||||||||||||||||
| 五年IF (数据来源于网友提供) | 6.097数据由网友[海旭]收集提供 | |||||||||||||||||||||||||
| h-index | 47 | |||||||||||||||||||||||||
| CiteScore ( 2026年6月最新版) |
| |||||||||||||||||||||||||
| 期刊简介 |
| |||||||||||||||||||||||||
| 期刊官方网站 | http://cancerci.biomedcentral.com | |||||||||||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||||||||||
| 期刊投稿网址 | https://submission.nature.com/new-submission/12935/3 | |||||||||||||||||||||||||
| 作者指南网址 | http://cancerci.biomedcentral.com/submission-guidelines | |||||||||||||||||||||||||
| 该期刊中国学者近期发文 - New | RETRACTION: MicroRNA-214-3p inhibits proliferation and cell cycle progression by targeting MELK in hepatocellular carcinoma and correlates cancer prognosis Author: Li, Yue; Li, You; Chen, Yao; Xie, Qian; Dong, Ningning; Gao, Yanjun; Deng, Huan; Lu, Chunhua; Wang, Suihai Journal: CANCER CELL INTERNATIONAL. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1186/s12935-026-04327-x Leveraging the germ layer development patterns to predict prognosis and identify MEST as a novel therapeutic target in glioma (vol 26, 68, 2026) Author: Zhang, Wei; Xia, Shunjin; Xiao, Yanming; Liu, Hongwei; Wang, Chaoqian; Dai, Luohuan; Chen, Yinhua; Lin, Xuelei; Liu, Hongyi; Jiang, Nian Journal: CANCER CELL INTERNATIONAL. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1186/s12935-026-04294-3 TRPM2: a pivotal player in tumor progression and a promising therapeutic target (vol 25, 356, 2025) Author: Chen, Zhigang; Wu, Zhenheng; Xu, Tianhan; Yu, Fuqian; Wang, Dongmei Journal: CANCER CELL INTERNATIONAL. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1186/s12935-026-04255-w RETRACTION: M3 muscarinic acetylcholine receptors regulate epithelial-mesenchymal transition, perineural invasion, and migration/metastasis in cholangiocarcinoma through the AKT pathway Author: Feng, Yujie; Hu, Xiao; Liu, Guangwei; Lu, Lianfang; Zhao, Wei; Shen, Fangzhen; Ma, Kai; Sun, Chuandong; Zhu, Chengzhan; Zhang, Bingyuan Journal: CANCER CELL INTERNATIONAL. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1186/s12935-026-04301-7 | |||||||||||||||||||||||||
| 期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足Cancer Cell International的语言要求,还能让Cancer Cell International编辑和审稿人得到更好的审稿体验,让稿件最大限度地被Cancer Cell International编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢(6篇) 。
提交文稿 | |||||||||||||||||||||||||
| 是否OA开放访问 | Yes | |||||||||||||||||||||||||
OA期刊相关信息![]() | 文章处理费:需要( GBP2190; USD2990; EUR2490; ) 文章处理费豁免:查看说明 其他费用:没有 期刊主题关键词:cancer cell biology、cell culture 相关链接:Aims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | |||||||||||||||||||||||||
| 通讯方式 | BIOMED CENTRAL LTD, 236 GRAYS INN RD, FLOOR 6, LONDON, ENGLAND, WC1X 8HL | |||||||||||||||||||||||||
| 出版商 | BioMed Central | |||||||||||||||||||||||||
| 涉及的研究方向 | ONCOLOGY- | |||||||||||||||||||||||||
| 出版国家或地区 | ENGLAND | |||||||||||||||||||||||||
| 出版语言 | English | |||||||||||||||||||||||||
| 出版周期 | Irregular | |||||||||||||||||||||||||
| 出版年份 | 2001 | |||||||||||||||||||||||||
| 年文章数 | 479点击查看年文章数趋势图 | |||||||||||||||||||||||||
| Gold OA文章占比 | 100.00% | |||||||||||||||||||||||||
| 研究类文章占比: 文章 ÷(文章 + 综述) | 71.19% | |||||||||||||||||||||||||
| 期刊分区表预警名单 | 2026年03月发布的新锐学术版:不在预警名单中 2025年03月发布的2025版:不在预警名单中 2024年02月发布的2024版:不在预警名单中 2023年01月发布的2023版:不在预警名单中 2021年12月发布的2021版:预警等级:中 2020年12月发布的2020版:不在预警名单中 | |||||||||||||||||||||||||
| 《新锐期刊分区表》 ( 2026年3月发布) | 点击查看期刊分区表趋势图
| |||||||||||||||||||||||||
| 期刊分区表 ( 2025年3月升级版) |
| |||||||||||||||||||||||||
| 期刊分区表 ( 2023年12月旧的升级版) |
| |||||||||||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE) Scopus (CiteScore) Directory of Open Access Journals (DOAJ) | |||||||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1475-2867%5BISSN%5D | |||||||||||||||||||||||||
| 平均审稿速度 | 网友分享经验: 平均1月 | |||||||||||||||||||||||||
| 平均录用比例 | 网友分享经验: 约50% | |||||||||||||||||||||||||
| 版面费/APC文章处理费信息 | 文章处理费:需要( GBP2190; USD2990; EUR2490; ) 文章处理费豁免:查看说明 其他费用:没有 LetPub提供文章处理费(APC)支持服务,可以用人民币支付版面费啦! | |||||||||||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)后论文在Cancer Cell International顺利发表。
快看看作者怎么说吧:服务好评 论文致谢(6篇) 。 提交文稿 | |||||||||||||||||||||||||
| 期刊常用信息链接 |
| |||||||||||||||||||||||||
|
|
| |
| 中国学者近期发表的论文 | |
| 1. | RETRACTION: MicroRNA-214-3p inhibits proliferation and cell cycle progression by targeting MELK in hepatocellular carcinoma and correlates cancer prognosis Author: Li, Yue; Li, You; Chen, Yao; Xie, Qian; Dong, Ningning; Gao, Yanjun; Deng, Huan; Lu, Chunhua; Wang, Suihai Journal: CANCER CELL INTERNATIONAL. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1186/s12935-026-04327-x PubMed DOI |
| 2. | Leveraging the germ layer development patterns to predict prognosis and identify MEST as a novel therapeutic target in glioma (vol 26, 68, 2026) Author: Zhang, Wei; Xia, Shunjin; Xiao, Yanming; Liu, Hongwei; Wang, Chaoqian; Dai, Luohuan; Chen, Yinhua; Lin, Xuelei; Liu, Hongyi; Jiang, Nian Journal: CANCER CELL INTERNATIONAL. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1186/s12935-026-04294-3 PubMed DOI |
| 3. | TRPM2: a pivotal player in tumor progression and a promising therapeutic target (vol 25, 356, 2025) Author: Chen, Zhigang; Wu, Zhenheng; Xu, Tianhan; Yu, Fuqian; Wang, Dongmei Journal: CANCER CELL INTERNATIONAL. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1186/s12935-026-04255-w PubMed DOI |
| 4. | RETRACTION: M3 muscarinic acetylcholine receptors regulate epithelial-mesenchymal transition, perineural invasion, and migration/metastasis in cholangiocarcinoma through the AKT pathway Author: Feng, Yujie; Hu, Xiao; Liu, Guangwei; Lu, Lianfang; Zhao, Wei; Shen, Fangzhen; Ma, Kai; Sun, Chuandong; Zhu, Chengzhan; Zhang, Bingyuan Journal: CANCER CELL INTERNATIONAL. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1186/s12935-026-04301-7 PubMed DOI |
| 5. | CD8+ T cell exhaustion driven by metabolic reprogramming Author: Deng, Wenzhi; Li, Chunhong; Wang, Qiang; Jiang, Xiulin; Xie, Yongzhi Journal: CANCER CELL INTERNATIONAL. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1186/s12935-026-04287-2 PubMed DOI |
| 6. | Clonal hematopoiesis in the pathogenesis of non-hematologic diseases with therapeutic potential Author: Lei, Lu; Xiong, Jie Journal: CANCER CELL INTERNATIONAL. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1186/s12935-026-04285-4 PubMed DOI |
| 7. | Targeting cell death: a promising approach for colorectal cancer therapy Author: Xiao, Chengfeng; Oyang, Linda; Jiang, Xianjie; Li, Shizhen; Peng, Qiu Journal: CANCER CELL INTERNATIONAL. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1186/s12935-026-04261-y PubMed DOI |
| 8. | RNA modifications and cancer ferroptosis Author: Xie, Yingda; Sun, Bo; Chen, Wenjuan; Jia, Xueying; Fan, Yitao; Xu, Ziyi; Liu, Hongyan; Gu, Xinyu; Ma, Fuqiang Journal: CANCER CELL INTERNATIONAL. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1186/s12935-026-04279-2 PubMed DOI |
| 9. | RETRACTION: TAZ inhibition promotes IL-2-induced apoptosis of hepatocellular carcinoma cells by activating the JNK/F-actin/mitochondrial fission pathway Author: Ji, Kaihua; Lin, Kaili; Wang, Yan; Du, Liqing; Xu, Chang; He, Ningning; Wang, Jinhan; Liu, Yang; Liu, Qiang Journal: CANCER CELL INTERNATIONAL. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1186/s12935-026-04286-3 PubMed DOI |
| 10. | The cancer-testis lncRNA AC007271.3 acts as a decoy of MBP-1 and promotes chemotherapy resistance by inhibiting ferroptosis via c-Myc/GPX4 pathway in oral squamous cell carcinoma Author: Qiao, Zihe; Wu, Qingqing; Zhang, Xueni; Wang, Mohan; Zheng, Zenan; Fonseca, Shanoi T.; Lv, Xiaozhi Journal: CANCER CELL INTERNATIONAL. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1186/s12935-026-04281-8 PubMed DOI |
|
|
|
投稿状态统计: 我要评分: | ||||||||||||||||
| 投稿前担心稿件结构或语言不够规范?试试稿件自查工具,一键检测 >> | ||||||||||||||||
|
||||||||||||||||
同领域作者分享投稿经验:共790条 |
||||||||||||||||
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2026 中国: LetPub上海 网站备案号:沪ICP备10217908号-1
沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)
增值电信业务经营许可证:沪B2-20211595 网络文化经营许可证:沪网文[2023]2004-152号
礼翰商务信息咨询(上海)有限公司 办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室